Drugs / CD19 Universal CAR-γδ T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06106893 | Jan 2024 → Dec 2025 overdue | systemic lupus erythematosus | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19 Universal CAR-γδ T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06106893 ↗ |
| Modality | Cell therapy | “CAR-T cell treatment” NCT06106893 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT06106893 ↗ |